LP
NVS icon

LMR Partners’s Novartis NVS Stock Holding History

LMR Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334M Buy
2,132,500
+828,700
+64% +$124M 1.25% 12
2026
Q1 		$199M Buy
1,303,800
+441,000
+51% +$67.6M 0.44% 19
2025
Q4 		$119M Buy
862,800
+733,100
+565% +$96M 0.22% 37
2025
Q3 		$16.6M Hold
129,700
– – 0.07% 207
2025
Q2 		$15.7M Buy
129,700
+43,700
+51% +$4.93M 0.11% 192
2025
Q1 		$9.59M Buy
+86,000
New +$9.16M 0.09% 252

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LMR Partners's NVS Position: Q2 2026 in Review

LMR Partners increased its Novartis (NVS) stake by 257% in Q2 2026, buying an estimated $16.6M and bringing the position to 153,726 shares worth $24.1M. The position accounts for 0.09% of the portfolio, ranked #202.

LMR Partners first reported a position in NVS in Q2 2023 and has held it in 3 quarters since. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • LMR Partners held 153,726 shares of Novartis worth $24.1M as of Q2 2026.
  • LMR Partners bought 110,621 Novartis shares in Q2 2026, an estimated $16.6M.
  • Novartis made up 0.09% of LMR Partners's portfolio in Q2 2026, its #202 holding.
  • LMR Partners first reported a position in Novartis in Q2 2023 and has held it in 3 quarters since.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.